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Abstract 
A paper reporting findings relevant to safety of the genetically modified (GM) maize NK603 and the herbicide 
Roundup (Séralini et al., Food Chem Toxicol. 50:4221–4231, 2012) was retracted against the wishes of the authors, and 
subsequently republished in another peer-reviewed journal (Séralini et al. Environ Sci Europe, doi:10.1186/s12302-
014-0014-5, 2014). These events exemplify a trend in which disputes, between interest groups vying for retraction 
and republication of papers that report controversial results, overshadow the normal scientific process in which 
peer-reviewed publication stimulates new research, generating new empirical evidence that drives the evolution of 
scientific understanding. This paper reviews the current status of research on safety of NK603 maize and Roundup 
herbicide for human and livestock health, and attempts to glean from recent developments insights relevant to risk 
assessment policy for GM crops and pesticides, as well as relevant to the scientific process in general. Our analysis 
of currently published evidence confirms NK603 and Roundup are kidney and liver toxicants at levels below current 
regulatory thresholds. Consequently, the regulatory status of NK603, glyphosate and Roundup requires reevaluation. 
Additionally, preliminary evidence indicates Roundup and NK603, individually and in combination, may increase 
tumor incidence and mortality. Follow-up long-term carcinogenicity studies, using test animal strains and numbers of 
animals that assure robust conclusions, are required to confirm/refute this preliminary evidence. The inherent tension 
between the scientific process and commercial interests of product developers necessitates implementation of safe-
guards that protect the scientific process and prevent degeneration of Science to Re-Science (typified by retraction 
and republication disputes).
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Introduction
In November 2013, the editors of the journal Food and 
Chemical Toxicology (FCT) retracted [1] a controversial 
research paper, with implications for public, animal and 
ecosystem health [2], against the desires of the authors. 
In June 2014, this paper was republished in the refereed 
journal Environmental Sciences Europe (ESEU) [3].
Retracted over a year after publication, this paper pre-
sented clear evidence regarding the toxicity of NK603 
and Roundup herbicide. Earlier, 90-day toxicity studies 
generated data [4, 5] indicating that the genetically modi-
fied (GM) maize, event NK603, (tested in three different 
doses) may be implicated in kidney and liver toxicity in 
Sprague–Dawley rats. Séralini et al. [2, 3] presented evi-
dence from longer term toxicity studies that confirmed 
earlier findings. This work also reported that Roundup 
herbicide formulation (tested in three different doses) 
causes liver and kidney toxicity at levels well below the 
regulatory threshold set for glyphosate, alone. This was 
the first study to investigate effects of a Roundup for-
mulation. All earlier studies investigated glyphosate, 
the herbicidal ingredient of Roundup, in isolation. The 
genetically modified maize NK603, Roundup and the two 
in combination were also reported to increase mortality 
and tumor incidence. The study was designed as a toxi-
cological study, not as a carcinogenesis study. Therefore, 
the tumor incidence and mortality results were reported, 
according to OECD guidelines for chronic toxicity 
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studies [6], as secondary observations requiring follow-
up using a study design intended to systematically assess 
carcinogenesis.
With Séralini et  al. [2] once again part of the peer-
reviewed scientific literature, the present article attempts 
to glean from the events surrounding this article insights 
relevant to the risk assessment process for genetically 
modified crops and their required co-technologies, such 
as herbicides, and insights relevant to the broader pro-
cess by which scientific knowledge is generated. The arti-
cle also summarizes the current state of research related 
to the safety of the genetically modified maize NK603 
and the herbicide Roundup.
Initial publication and public dialog
Vigorous public discussion of Séralini et  al. [2] com-
menced through multiple communication channels within 
hours of publication. Reviewing this exchange, it is clear 
that much of it consisted of robust discussion among sci-
entists and regulators aimed at clarifying various aspects 
of the research results and understanding the ramifications 
for regulatory policy related to safety assessment of GM 
crops and pesticides. However, it soon became apparent 
that, superimposed on this scientific discussion, there was 
an industry-driven media and lobbying campaign aimed 
at both the research and research team. An article in The 
Guardian [7] described the campaign as “a triumph for 
the scientific and corporate establishment which has used 
similar tactics to crush other scientists”.
The Science Media Center (SMC) and its spinoffs 
in Japan, Canada, Australia, and New Zealand, which 
receive substantial funding from agricultural biotech 
companies [8], played a central role in this campaign, 
broadcasting communications aimed at science journal-
ists. These communication efforts succeeded in reducing 
press coverage of the Seralini publication world-wide, 
according to the head of SMC [9].
A second element was an email campaign urging sci-
entists to write to FCT demanding that Séralini et al. [2] 
be retracted (documented in Langridge [10]). The result-
ant letters represented the majority of letters published in 
FCT that were critical of the paper. A third element of the 
campaign was a petition sponsored by AgBioWorld [11], 
which has long-standing industry links [12].
Two months after publication of Séralini et al. [2], the 
Séralini research group published a systematic response 
to criticisms voiced in letters published in FCT [13].
Consecutively to the month-long campaign by the bio-
technology industry, FCT created a new position, Asso-
ciate Editor for Biotechnology, to which they appointed 
Richard Goodman, a past employee of Monsanto. The 
major agricultural biotechnology companies continue 
to fund his research at the University of Nebraska [14]. 
Goodman has been closely linked to the International 
Life Sciences Institute (ILSI), an industry-funded organi-
zation with a history of lobbying for industry-friendly 
risk assessment regulations for GM crops and pesticides. 
World Health Organization (WHO) has barred ILSI from 
participating in WHO safety standards setting processes 
[15], following publication of reports by WHO in 2001 
and 2003, criticizing ILSI [16, 17].
Imposed retraction
Not long after Goodman’s appointment as Associate 
Editor for Biotechnology, Séralini and colleagues were 
requested to provide all raw data to FCT for review 
and were subsequently informed their paper would be 
retracted. Although the Editor-in-Chief published assur-
ances that Goodman did not have access to the raw data 
provided to FCT, it is clear that he was involved in the 
internal review, although this involvement was later ter-
minated at Séralini’s request [18].
The essence of the retraction notice [1] is as follows:
“A more in-depth look at the raw data revealed that 
no definitive conclusions can be reached with this 
small sample size regarding the role of either NK603 
or glyphosate in regards to over-all mortality or 
tumor incidence”.
“Ultimately, the results presented (while not incor-
rect) are inconclusive, and therefore do not reach 
the threshold of publication for Food and Chemical 
Toxicology”.
Subsequently, in response to several letters to FCT 
criticizing the retraction, Hayes published an expanded 
explanation [18], the core of which is as follows:
“According to the COPE [Committee on Publication 
Ethics] guidelines, ‘Journal editors should consider 
retracting a publication if… they have clear evidence 
that the findings are unreliable, either as a result of 
misconduct (e.g. data fabrication) or honest error 
(e.g. miscalculation or experimental error).’ [19] …. 
The data are inconclusive, therefore the claim (i.e., 
conclusion) that Roundup Ready maize NK603 and/
or the Roundup herbicide have a link to cancer is 
unreliable”.
“The review of the data made it clear that there was 
no misconduct. However, to be very clear, it is the 
entire paper, with the claim that there is a defini-
tive link between GMO and cancer that is being 
retracted”.
Hayes’ justification for retraction contains questionable 
points:
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First, the central findings of the study, that Roundup 
and NK603 together and individually caused hepatic and 
renal damage in the exposed Sprague–Dawley rats, are 
not inconclusive. These findings, based on biochemical 
measurements from blood samples, are statistically signif-
icant and were generated from numbers of animals recog-
nized by OECD as appropriate for chronic toxicity studies 
(n =  10 animals per group). In and of themselves, these 
findings warrant publication. Hayes ignores these central 
findings and focuses on tumors and mortality only.
Second, Hayes’ justification hinges on the misunder-
standing that Séralini claimed a “definitive link between 
GMO and cancer”. This is clearly incorrect. The actual 
conclusions of the paper are as follows:
1. “[…] lower levels of complete agricultural glypho-
sate herbicide formulations, at concentrations well 
below officially set safety limits, induce severe hor-
mone-dependent mammary, hepatic and kidney dis-
turbances”,
2. “[…] disruption of biosynthetic pathways that may 
result from overexpression of the EPSPS transgene in 
the GM NK603 maize can give rise to comparable 
pathologies  [mammary, hepatic and kidney distur-
bances]  that may be linked to abnormal or unbal-
anced phenolic acids metabolites, or related com-
pounds. Other mutagenic and metabolic effects of 
the edible GMO cannot be excluded. This will be the 
subject of further studies”,
3. “This study represents the first detailed documen-
tation of long-term deleterious effects arising from 
the consumption of GM R[oundup]-tolerant maize 
and of R[oundup]…”, 
and
4. “[…] significant biochemical disturbances and physi-
ological failures documented in this work confirm the 
pathological effects of these GMO and R[oundup] treat-
ments in both sexes, with different amplitudes. We pro-
pose that agricultural edible GMOs and formulated 
pesticides must be evaluated very carefully by long term 
studies to measure their potential toxic effects”.
Moreover, the article does not contain the word “can-
cer”. Although the paper reports the occurrence of 
tumors, it does not equate these with cancer, and it 
reports them in the context of OECD Guideline 452 for 
chronic toxicity studies, which requires that, if, during a 
chronic toxicology study, increased mortality, or lesions, 
such as tumors, are observed, these must be reported [6].
Third, Hayes’s justification is based on an incorrect 
reading of the COPE guidelines [20], which recommend 
retraction if “findings are unreliable, either as a result of 
misconduct (e.g. data fabrication) or honest error (e.g. 
miscalculation or experimental error)…”.
Hayes inappropriately applied this recommendation by 
equating “inconclusive” with “unreliable”. These are not syn-
onymous. Furthermore, as Schubert [19], Meyer and Hilbeck 
[21] and others have pointed out, if Hayes’ reading of this 
recommendation were applied uniformly, most of the sci-
entific literature would have to be retracted. It is the nature 
of research results that they are inconclusive. Or, as David 
Suzuki asserts: “the very nature of science, is that most of our 
ideas at the cutting edge of knowledge are wrong. That’s how 
science progresses.”… “But we forget that” [22].
Regarding this, Portier et al. [23] state, “To our knowl-
edge, there is no precedent for ’inconclusive data‘ being 
a reason for retraction for Elsevier or other publishers, 
or elsewhere in the scientific literature. To single out this 
one study for retraction is almost certainly due to the 
controversy following its publication”.
Fourth, FCT does not adhere consistently to the “pol-
icy” upon which Hayes based his retraction of Séralini 
et al. [2], as Séralini et al. [24] state:
“FCT’s retraction of our paper, while not retracting 
studies—Zhang et al. [25] and Hammond et al. [4]—
is an example of unscientific double standards. The 
decision to retract our paper appears to be result-
driven, in that findings of safety in Zhang et al. [25] 
and Hammond et al. [4] have not been subjected to 
critical analysis and have been allowed to stand, 
whereas our findings of risk have been viewed with 
suspicion and forcibly retracted. As a result, eco-
nomic interests have been given precedence over 
public health”.
Meyer and Hilbeck [21] have published an in-depth 
comparative analysis that included both Séralini et  al. 
[2] and Hammond, et  al. [4], which comes to the same 
conclusion.
It may be that the validity of Hayes’ decision has also 
been questioned within Elsevier since, as of January 2015, 
he has been replaced as senior editor at FCT, and Good-
man is no longer listed as part of the FCT editorial board.
Another, more recent publication, Reznick [26] also 
agrees that, “inconclusiveness, by itself, is not a sufficient 
reason for retracting an article…”. Despite, seeming to 
be critical of the conclusions of Séralini et al. [2, 3], this 
article also makes clear that retraction due to inconclu-
siveness is not in accordance with the COPE guidelines 
[20] for retraction of published papers. Reznick [26] also 
ask the question, “How was a paper that the editors said 
did not meet the journal’s scientific standards approved 
for publication in the first place?” The author concludes, 
“Journals that are reviewing studies with significant 
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scientific and social implications should take special care 
to ensure that peer review is rigorous and fair”.
Republication
Séralini et al. [2] has now been republished in the open 
access journal Environmental Sciences Europe (ESEU). 
Unsurprisingly, controversy has already arisen regard-
ing the republished paper. According to a journalist at 
Nature [27], ESEU “conducted no scientific peer review” 
of Séralini, et  al. [3], and the “role of the three review-
ers that ESEU hired was to check that there had been 
no change in the scientific content of the paper”. Henner 
Hollert, editor-in-chief of ESEU, is quoted as saying that 
this approach was taken because a scientific peer review 
“had already been conducted by Food and Chemical Tox-
icology, and had concluded there had been no fraud nor 
misrepresentation”.
Industry advocates have argued that this means that 
the paper was republished without peer review, and 
Reznick [26] reiterates this view. However, the perspec-
tive of ESEU seems to be that they accepted as valid 
FCT’s original peer review, and used their own peer 
reviewers to verify that the scientific content of the 
resubmitted paper was unchanged. Hence, the conclu-
sions of the previously published peer-reviewed paper in 
FCT still stand.
Séralini et al. [3] have also provided all raw data perti-
nent to the study as an on-line supplement. In an accom-
panying commentary, Séralini et  al. [28] state that all 
raw data used in regulatory assessments of GM crops 
and pesticides should also be made public. This point 
has also been raised by others [29]. Although biosafety 
data on GMOs are in the public domain in the EU, pes-
ticide data are not, and in many countries, such as the 
US, large portions of the documentation submitted for 
approvals of both GMOs and pesticides are classified as 
confidential business information and are not accessible 
to the public.
Séralini et  al. [28] also point to another area where 
reform is needed, explaining that currently, GM crop 
and pesticide developers are allowed to submit to reg-
ulators, as evidence of safety of their products, data 
generated in their own laboratories or in contract lab-
oratories under their supervision. Séralini et  al. [28] 
suggest that the conflicts of interest inherent in this 
arrangement can be avoided by having such research 
conducted by independent laboratories. They suggest 
companies still pay for the research, at levels compara-
ble to current costs, but public tender to carry out the 
research independent of the company that developed 
the product would recruit independent researchers. 
Others have suggested a similar approach for assessing 
biomedical technologies [30].
Safety of NK603, glyphosate and roundup—
current status of the science
Careful comparison of Séralini et  al. [3] and [2] makes 
clear that the datasets of the two papers are identical. 
The authors’ interpretation of those data and their con-
clusions are also unchanged. The main differences are 
clearer presentation and clarification of certain points 
that had been the subject of debate regarding the first 
version of the paper.
The two conclusions presented in the original paper 
still stand. The first was that long-term dietary exposure 
to genetically modified NK603 maize is linked with statis-
tically significant differences in blood parameters indica-
tive of kidney deficiency and liver congestion/necrosis.
This was not a new finding. Séralini et al. [2, 3] is con-
firmatory of earlier reports of small but statistically sig-
nificant changes in liver and kidney function linked to 
90-day exposure to NK603. Hammond et  al. [4] inter-
preted these changes as not biologically significant, while 
de Vendômois et al. [5] interpreted them as potential early 
signs of liver and kidney toxicity. The dataset of the lat-
ter study was generated in Monsanto’s own laboratories, 
submitted to EU regulators as part of the approval process 
for NK603 in Europe, and provided under court order to 
de Vendômois et al. by the Swedish Board of Agriculture.
Séralini et al. [2, 3] was designed as a follow-up to these 
two reports. It confirmed that the small but statistically 
significant changes observed in studies of shorter dura-
tion do escalate into more severe, statistically signifi-
cant organ pathologies when duration of exposure was 
extended beyond 90 days to 2 years.
The second conclusion was that long-term dietary expo-
sure to formulated Roundup herbicide is linked with high 
statistical significance to substantial increases in inci-
dence of kidney deficiency and liver congestion/necrosis. 
It has long been recognized that glyphosate exposure at 
levels above regulatory limits can cause liver and kidney 
failure [31]. The new contribution of Séralini et al. [2, 3] 
is that the concentrations of formulated Roundup found 
to cause liver and kidney damage were as low as 0.05 ppb 
(containing 50 ng/L of glyphosate), well below safety lim-
its for glyphosate in EU drinking water. This limit was set 
based on studies of glyphosate in isolation, not Roundup 
formulations. Roundup formulations are more effective 
than glyphosate alone as herbicides, because the adjuvants 
included in Roundup, allow glyphosate to penetrate plant 
tissues more effectively, thereby increasing toxicity to ani-
mals. Likewise the adjuvants would increase penetration 
of animal tissues thereby increasing toxicity to animals. 
The findings of Séralini et al. [2, 3] are also consistent with 
the epidemiological evidence recently published by Jaya-
sumana et al. [32, 33], linking Roundup to kidney failure 
in sugar cane plantation workers.
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As in their earlier paper, Séralini et  al. [3] also report 
increased mortality and tumor incidence in rats fed 
NK603 and Roundup, either together or separately. These 
observations are presented as preliminary findings, and 
the authors suggest multiple lines of research to further 
test their observations.
A recent report from the International Agency for 
Research on Cancer (IARC) concluded that glyphosate is 
“probably carcinogenic to humans” (Group 2A chemical) 
[34]. IARC concluded that evidence for the carcinogenic-
ity of glyphosate in animal studies was conclusive, and 
cited independent support from mechanistic evidence 
(genotoxicity and oxidative stress). However, data in 
humans were limited; therefore, glyphosate was classified 
as “probably carcinogenic in humans”.
The European Food Safety Authority (EFSA) of the 
European Commission had sharply criticized Séralini 
et  al. [2] and rejected its utility in a regulatory setting 
[35]. However, even before the paper was republished, 
the European Commission announced [36] that they 
would offer funding for research designed to test the 
observations of Séralini et  al. The French government 
also announced they would fund studies to follow-up 
Séralini et al. [2]. Unfortunately, the 3–6-month duration 
and limited scope of measurements proposed for the new 
French study make it inadequate to serve as a meaning-
ful follow-up. The forum where design of this protocol 
was discussed included Monsanto and other agricul-
tural biotechnology companies—as well as CRIIGEN, the 
research organization of the Séralini group. CRIIGEN 
withdrew from this forum stating that the protocol pro-
posed was inadequate [37].
The protocols for the EFSA and French studies have 
undergone a number of changes since first announced. 
The original French protocol was dropped and a new 
protocol, GMO90+, was developed that is integrated 
with the protocol designed by EFSA. However, it retains 
the limitation of the former protocol in that it is only 
3–6  months in duration [38] and therefore fails to rep-
licate the time frame of Séralini et  al. [2, 3]. The EFSA 
study includes two sub-studies termed, GRACE and 
G-TwYST [38]. GRACE only replicates the 90-day time 
course of Hammond [4]. G-TwYST replicates many of the 
features of Séralini et al. [2, 3], but has serious limitations, 
such as using NK603 maize that has been sprayed only 
once with Roundup. This dosage was selected because it 
was considered “best practice” [38]. Although this may 
have been the best practice 10  years ago, today glypho-
sate resistance of noxious weeds in both North America 
and Latin America makes at least two, and often three, 
applications of Roundup necessary. Currently, both the 
EFSA and the French studies are in progress [38].
Role of rat strain in toxicological 
and carcinogenesis studies
Selection of an appropriate animal model is an essen-
tial prerequisite for credible and relevant results from 
feeding studies. This was a point of criticism of Séra-
lini et al. [2, 3], even though their choice was consistent 
with OECD guidelines and current best practice. OECD 
Guideline 452 for Testing of Chemicals (pg 4) recom-
mends, “The chronic toxicity study should be carried out 
in animals from the same strain and source as those used 
in preliminary toxicity study(ies) of shorter duration” [6].
Séralini et al. [2, 3] was designed as a follow-on study 
to Hammond et  al. [4]. Since Hammond et  al. used 
Sprague–Dawley (SD) rats, it was correct, according to 
OECD guidelines [6], for Séralini et  al. to also use this 
strain. Séralini et al. [2, 3] interpret their finding of liver 
and kidney toxicity as being consistent with Hammond 
et  al. [4], confirming that, the observations reported by 
Hammond et al. were early signs of liver and kidney tox-
icity. It should be pointed out that the two studies pro-
cured SD rats from different sources. This is an undefined 
variable since sub-lines of outbred stocks of rats (such as 
SD), propagated in isolation, can undergo genetic drift, 
complicating comparisons of results between studies.
Increasing sample size is one solution to limitations 
resulting from both variations in strains from different 
suppliers and genetic variation within outbred strains. 
Kacew and Festing [39] point out this has economic 
impacts, but argue for an alternative solution: “It is pos-
sible to incorporate more than one strain of [inbred] 
animals into existing experimental designs for carcino-
genesis screening without increasing the total number 
of animals or paying any statistical penalty for doing so”. 
At present, OECD guidelines [6, 40] largely leave animal 
model selection up to the investigator. More stringent 
guidelines, based on current best practice, could signifi-
cantly improve rigor and consistency of toxicology and 
carcinogenicity assessments.
Policy ramifications for safety assessment of GM 
crops and pesticides
The papers published by Séralini et  al. [2, 3] bring into 
focus two key issues relevant to government policy for 
safety assessment of GM crops. First, they make clear 
that current industry feeding trials, which at most con-
tinue for 90 days, or about 10 percent of the lifespan of 
the test animals, are not adequate for food and feed prod-
ucts meant for daily use. Long-term, if not life-long, tox-
icity and carcinogenicity studies are called for. EFSA and 
other regulatory agencies have been edging away from 
requiring feeding studies of any kind for GM crops [41]. 
Hopefully, these results will reverse this trend.
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The second issue is the need to assess pesticides and 
GM crops together, and in the context in which they are 
used in agricultural practice. Based largely on in vitro tis-
sue culture studies, Roundup formulations are more toxic 
than the “active” ingredient glyphosate alone [42, 43]. The 
in vivo studies reported by Séralini et al. [2, 3] also sug-
gest Roundup may be more toxic than glyphosate alone 
at levels below officially set safety limits, which were 
established based on studies of glyphosate alone.
The above issues, as well as issues raised in Séralini 
et al. [28] point to structural biases in regulatory science 
processes that limit the ability of these processes to pro-
tect public, animal and ecosystem welfare. Rectifying this 
situation requires substantive changes in safety assess-
ment policies. Changes in the right direction would be, 
for example (a), requiring risk assessments of real tech-
nology package combinations, and of actual formula-
tions used in agriculture, like Roundup, and (b) requiring 
independence of risk assessment research from corporate 
influence or control.
With the research of Séralini et  al. [2] restored as 
a formal part of the scientific literature [3], it is now 
incumbent on the regulatory authorities to grapple 
with evidence presented therein and modify policy 
accordingly.
Regulators in many countries judge the acceptabil-
ity of studies for use in regulatory assessment based on 
whether or not they were carried out according to GLP 
(Good Laboratory Practice) standards and according 
to OECD (Organization for Economic Cooperation and 
Development) guidelines. Séralini, et al. [3] resolves ear-
lier ambiguity, making clear that their research was car-
ried out according to GLP in a GLP accredited laboratory.
It is important to note that OECD guidelines do not 
exist for safety assessment of GM crops. Typically, regu-
lators have allowed industry to adapt OECD guidelines 
for toxicity testing of chemicals, in particular OECD 
guideline 408 (sub-chronic, 90-day, toxicity protocol) 
[37], for animal feeding studies assessing GM crop safety. 
Séralini et al. [2, 3] was designed as a follow-on study to 
Hammond et al. [4], and therefore is consistent with the 
same adaptation of OECD guideline 408 used by Ham-
mond et al. [4]. However, Séralini et al. [2, 3] added rigor 
in three ways. (a) They used three doses of NK603 and 
Roundup. OECD 408 requires 3 doses, but most indus-
try GM crop studies, including Hammond et al. [4], have 
used only two. Regulators have accepted studies that 
follow this model, despite this shortcoming. (b) Séra-
lini et  al. [2, 3] systematically report observations on 
34 organs and 56 blood parameters analyzed at 11 time 
points, which is a much broader dataset than that recom-
mended in OECD 408 and reported by Hammond et al. 
[4]. (c) They extended the time scale of the study from 
90 days to 2 years. However, Séralini et al. [2, 3] included 
n  =  10 animals in each treatment and control group, 
while Hammond et  al. [4] included n  =  20 animals in 
each group, but analyzed only 10 for blood parameters. 
Thus, the two studies generated biochemical data from 
equal numbers of animals. It should be pointed out, how-
ever, that Hammond et al. [4] did not disclose the crite-
ria that they used to select for analyzing 10 animals from 
among the 20 in each group.
In summary, the protocol used in Séralini et al. [2, 3] is 
at least as consistent with OECD protocols as was Ham-
mond et al. [4] and other studies regulators have accepted 
as evidence of the safety of GM crops. In addition, Séra-
lini et  al. [2, 3] included additional features making it 
more rigorous and generating additional useful data. 
Thus, it is justified that regulators take into account the 
evidence presented in Séralini et al. [2, 3] when consider-
ing the safety of NK603 and Roundup.
Scientific knowledge and the process of peer 
review: Re‑Publish or Perish?
The efforts to suppress the research findings of Séralini 
et al. [2] are not an isolated incident, but are exemplifying 
a trend that has emerged in recent years. In some cases, 
earlier efforts have lead to retraction; in others, pressure 
to retract has not achieved this result. Several examples 
are summarized by Waltz [44]. The most recent appar-
ent occurrence took place at the same journal, FCT, 
which retracted Séralini et  al. [2]. Mezzomo et  al. [45] 
was retracted by the editors without explanation, but was 
quickly republished in another peer-reviewed journal 
[46].
This trend raises larger scientific questions, two of 
which were expressed aptly by Portier et al. [23]:
“Will these data, which could well have been 
accepted by another journal, now be tainted beyond 
possibility for inclusion in usual weight-of-evidence 
reviews of the body of peer-reviewed science? Will 
the response to new science by interested parties now 
be focused on dueling attempts to have the paper 
retracted rather than on performing additional 
studies to replicate or refute the findings?”
The republication of Séralini et al. [2] as Séralini et al. 
[3] firmly establishes the data presented therein as peer-
reviewed science that must be considered by scientists 
and regulators alike. However, as events in the time sub-
sequent to republication attest, efforts to discredit these 
results continue.
Likewise, the republication makes it unlikely that 
Hayes’ enforced retraction will set a strong precedent, 
capable of supplanting the traditional response to a paper 
reporting new and controversial science—performing 
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additional research—with “dueling attempts to have the 
paper retracted”.
Portier et al. [23] raise another question bringing into 
sharp focus society’s loss if such a precedent were to be 
established: “Does this retraction strengthen the scien-
tific process, or does it confuse scientific discourse with 
public relations?”
In a letter to the editor of The Economist, Ellen Sil-
bergeld, Editor-in-Chief of Environmental Research, 
criticizes the imposed retraction, pointing out its nega-
tive impact on the peer-review process [47]: “I consider 
this a lamentable decision. I am troubled because as an 
editor I rely on the critical review of peers to determine 
acceptability of a paper submitted to my journal, and as 
a scientist, I rely upon the same system of peer review 
to receive fair review of my own work. This action intro-
duces a breach in the system of trust, which, with all its 
faults is, as Churchill said of democracy, better than any 
other process we have thought of up to this time”.
In contributing to the advancement of human welfare, 
science has been the goose that has laid many golden 
eggs of great benefit to the business sector. Yet when 
research results are not in line with short-term business 
priorities, there seems to be no hesitation to attempt to 
interfere with and manipulate the scientific process [23, 
44].
It is typical and justified for extraordinary research 
findings to be viewed with skepticism and subjected to 
more stringent scrutiny. As Stanley Prusiner, Nobel Prize 
Laureate, said [48], “While it is quite reasonable for sci-
entists to be skeptical of new ideas that do not fit within 
the accepted realm of scientific knowledge,….the best 
science often emerges from situations where results care-
fully obtained do not fit within the accepted paradigms”. 
But industry’s often well-funded and persistent lobbying 
is quite another matter. It introduces obstacles that can 
significantly slow or sidetrack the scientific process.
“Scientific discourse” whose priority is anything other 
than progressively unfolding more complete understand-
ing is not scientific discourse, but, as Portier et  al. [23] 
say, “public relations”. Taking this path risks killing the 
goose, and this threatens the greater public good, as well 
as industry’s own best interests.
Conclusions
Six notable developments emerge as a result of the repub-
lication of Séralini et al. [2] as Séralini et al. [3]:
1. Evidence is now part of the peer-reviewed scientific 
literature implicating NK603 maize and Roundup 
pesticide as chronic liver and kidney toxicants with 
potentially significant public and animal health con-
sequences. Séralini et  al. [2, 3] is not the first study 
on this topic, but builds on earlier studies [4, 5]. 
Although it is the first to assess the toxicity of formu-
lated Roundup, findings are consistent with the exist-
ing literature, documenting toxicity of glyphosate 
alone, showing that formulations are toxic at levels 
well below regulatory thresholds for glyphosate.
2. Now, it is time for critics of this evidence to pro-
vide substantive new empirical evidence that con-
tributes constructively to scientific dialog regarding 
NK603, glyphosate and Roundup. Four distinct lines 
of research need to be followed up at this time. First, 
the logical next step regarding liver and kidney tox-
icity will be to conduct detailed cause/effect studies. 
However, given the commercial implications of the 
toxicity findings, we can also expect additional rep-
licative studies to be conducted to confirm/refute 
the findings of Séralini et al. [2, 3]. Second, a formal, 
long-term carcinogenicity study, with larger num-
bers of animals, is needed to investigate the increased 
incidence of tumors and mortality unexpectedly 
observed by Séralini et  al. [2, 3]. Third, if carcino-
genicity is confirmed, follow-up cause/effect studies 
are needed to understand the biological processes 
involved. Finally, evidence of carcinogenicity should 
be followed up with comparative studies using a set 
of carefully selected experimental protocols and ani-
mal species/strains.
3. The currently extant evidence of liver and kidney tox-
icity in rats is sufficient to justify a thorough review 
of the regulatory status of NK603, glyphosate and 
Roundup.
4. Risk assessment policy needs to be upgraded to con-
sistently include assessment of chronic toxicity of 
GM crops and formulated pesticides, and to require 
that products be assessed, not as isolated “active 
ingredients”, but in formulations and combinations, 
and under conditions, used in actual practice.
5. The conflicts of interest inherent in allowing product 
developers to conduct the safety assessment research 
that serves as the basis for regulatory approval of 
their own products also need to be reconsidered.
6. The events surrounding the imposed retraction of 
Séralini et al. [2] point to the need to recognize the 
tension inherent between commercial interests of 
product developers and the scientific process, and to 
put in place at least basic safeguards to protect the 
latter. If this is not done, there is growing risk that the 
standard of the future will not be Science, but Re-Sci-
ence, which focuses, not on new research results that 
build humanity’s knowledge base, but on disputes 
among interest groups for (i) retraction of papers that 
report inconvenient results, and (ii) republishing—
the new Re-Science: Re-publish or Perish.
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